PT1399127E - Formulacoes de olopatadina para administracao topica - Google Patents

Formulacoes de olopatadina para administracao topica

Info

Publication number
PT1399127E
PT1399127E PT02737539T PT02737539T PT1399127E PT 1399127 E PT1399127 E PT 1399127E PT 02737539 T PT02737539 T PT 02737539T PT 02737539 T PT02737539 T PT 02737539T PT 1399127 E PT1399127 E PT 1399127E
Authority
PT
Portugal
Prior art keywords
formulacoes
olopatadin
topic administration
topic
administration
Prior art date
Application number
PT02737539T
Other languages
English (en)
Portuguese (pt)
Inventor
Ernesto J Castillo
Wesley Wehsin Han
Huixiang Zhang
Onkar N Singh
Haresh G Bhagat
Bullock Joseph Paul
Suresh C Dixit
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23162841&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1399127(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of PT1399127E publication Critical patent/PT1399127E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Inorganic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT02737539T 2001-06-27 2002-06-19 Formulacoes de olopatadina para administracao topica PT1399127E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30131501P 2001-06-27 2001-06-27

Publications (1)

Publication Number Publication Date
PT1399127E true PT1399127E (pt) 2005-07-29

Family

ID=23162841

Family Applications (1)

Application Number Title Priority Date Filing Date
PT02737539T PT1399127E (pt) 2001-06-27 2002-06-19 Formulacoes de olopatadina para administracao topica

Country Status (20)

Country Link
US (2) US6995186B2 (https=)
EP (1) EP1399127B1 (https=)
JP (5) JP4827374B2 (https=)
KR (1) KR100884711B1 (https=)
CN (1) CN1211125C (https=)
AR (1) AR034619A1 (https=)
AT (1) ATE295149T1 (https=)
AU (1) AU2002310461B2 (https=)
BR (1) BRPI0210707B8 (https=)
CA (1) CA2447924C (https=)
DE (1) DE60204142T2 (https=)
DK (1) DK1399127T3 (https=)
ES (1) ES2238574T3 (https=)
GC (1) GC0000397A (https=)
MX (1) MXPA03011947A (https=)
PL (1) PL205565B1 (https=)
PT (1) PT1399127E (https=)
TW (1) TWI231759B (https=)
WO (1) WO2003002093A1 (https=)
ZA (1) ZA200308771B (https=)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100055152A1 (en) * 2008-08-26 2010-03-04 Trutek Corporation Antihistamine and antihistamine-like nasal application, products, and method
TWI231759B (en) 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
US7977376B2 (en) 2001-06-27 2011-07-12 Novartis Ag Olopatadine formulations for topical nasal administration
US20050209312A1 (en) * 2004-03-19 2005-09-22 Bausch & Lomb Incorporated Carboxylic acid derivatives of doxepin formulations preserved with low-irritation preservative
KR20120136430A (ko) * 2004-04-08 2012-12-18 교와 핫꼬 기린 가부시키가이샤 안정성이 향상된 고형 제제 및 그 제조 방법
WO2005102313A1 (ja) * 2004-04-21 2005-11-03 Kyowa Hakko Kogyo Co., Ltd. 慢性副鼻腔炎の予防および／または治療剤
BRPI0512732A (pt) * 2004-06-28 2008-04-08 Alcon Inc formulações tópicas para tratamento de doenças alérgicas
MX2007005845A (es) * 2004-11-24 2007-07-04 Alcon Inc Metodo para entregar rocio nasal.
WO2006097458A1 (en) * 2005-03-15 2006-09-21 Nycomed Gmbh Novel combination
ES2437077T3 (es) 2005-07-08 2014-01-08 Senju Pharmaceutical Co., Ltd. Preparado oftálmico de absorción percutánea que comprende olopatadina
US20070077302A1 (en) * 2005-09-30 2007-04-05 Azaam Alli Methods for stabilizing ophthalmic compositions
WO2008067127A2 (en) 2006-11-09 2008-06-05 Alcon Research, Ltd. Water insoluble polymer matrix for drug delivery
US20080114076A1 (en) * 2006-11-09 2008-05-15 Alcon Manufacturing Ltd. Punctal plug comprising a water-insoluble polymeric matrix
AR063619A1 (es) * 2006-12-18 2009-02-04 Alcon Res Ltd Dispositivos y metodos para la administraicion de un farmaco oftalmico
WO2008093358A2 (en) * 2007-01-29 2008-08-07 Sun Pharmaceutical Industries Limited Aqueous topical solution containing olopatadine
PT2114367E (pt) * 2007-02-07 2016-02-01 Novartis Ag Formulações de olopatadina para administração nasal tópica
WO2008120249A1 (en) * 2007-03-30 2008-10-09 Sifi S.P.A. Pharmaceutical formulations based on apolar and polar lipids for ophthalmic use
KR20100014565A (ko) * 2007-04-11 2010-02-10 알콘 리서치, 리미티드 알레르기성 비염 및 알레르기성 결막염을 치료하기 위한 ｔｎｆａ의 억제제 및 항히스타민의 용도
WO2009031682A1 (ja) 2007-09-06 2009-03-12 Kyowa Hakko Kirin Co., Ltd. ジベンゾ[b,e]オキセピン誘導体含有点眼剤
CA2723954A1 (en) * 2008-05-19 2009-11-26 Alcon Research, Ltd. Pharmaceutical compositions having carboxyvinyl polymer and povidone polymer
WO2010027539A1 (en) * 2008-08-26 2010-03-11 Trutek Corp. Electrostatically charged mask filter products and method for increased filtration efficiency
JP2012509250A (ja) * 2008-08-28 2012-04-19 トルテック コーポレーション 抗ヒスタミン及び抗ヒスタミン様経鼻適用製品及び方法
US9458198B1 (en) 2009-06-26 2016-10-04 Shire Orphan Therapies Gmbh Cyclic peptide-based NPR-B agonists
PL2453872T3 (pl) * 2009-07-17 2013-12-31 Alcon Res Ltd Olopatadyna w postaci spreju do donosowego podawania dzieciom
WO2011027322A1 (en) 2009-09-03 2011-03-10 Ranbaxy Laboratories Limited Extended release dosage form containing olopatadine for oral administration
US8551938B2 (en) * 2009-09-25 2013-10-08 Alcon Research, Ltd. NPR-B agonists
WO2011038061A2 (en) 2009-09-25 2011-03-31 Alcon Research, Ltd. Novel npr-b agonists
CN102548536A (zh) * 2009-10-01 2012-07-04 爱尔康研究有限公司 奥洛他定组合物及其用途
WO2011075471A2 (en) 2009-12-18 2011-06-23 Alcon Research, Ltd. Novel npr-b agonists and methods of use for the treatment of c-type natriuretic peptide-mediated disorders
AR078446A1 (es) 2009-12-18 2011-11-09 Alcon Res Ltd Agonistas de npr-b. uso.
CN103140215A (zh) * 2010-07-21 2013-06-05 爱尔康研究有限公司 具有提高的溶解度特征的药物组合物
AU2011327785A1 (en) * 2010-11-08 2013-03-07 Healor Ltd. Buffered ophthalmic compositions and methods of use thereof
TWI544922B (zh) 2011-05-19 2016-08-11 愛爾康研究有限公司 高濃度歐羅派特錠（ｏｌｏｐａｔａｄｉｎｅ）眼用組成物
CN102885767A (zh) * 2012-11-02 2013-01-23 江苏吉贝尔药业有限公司 一种新的盐酸奥洛他定滴眼液及其制备方法
US20180215788A1 (en) 2017-02-01 2018-08-02 Shire Human Genetic Therapies, Inc. Compounds and Compositions for the Treatment of Ophthalmic Disorders
JP7037349B2 (ja) * 2017-06-23 2022-03-16 参天製薬株式会社 水溶性粘稠化剤を含有する医薬組成物
WO2018235935A1 (ja) * 2017-06-23 2018-12-27 参天製薬株式会社 水溶性粘稠化剤を含有する医薬組成物
TW202133861A (zh) * 2019-12-06 2021-09-16 日商東興藥品工業股份有限公司 含有歐羅派特錠的點鼻用組成物
CA3176584A1 (en) * 2020-03-31 2021-10-07 Santen Pharmaceutical Co., Ltd. Silver salt-containing ophthalmic aqueous composition filled in resin container
CN111700860A (zh) * 2020-07-09 2020-09-25 浙江尖峰药业有限公司 盐酸奥洛他定滴眼液及其制备方法
CN119318630B (zh) * 2024-10-16 2025-08-22 苏州欧康维视生物科技有限公司 一种阿托品药物组合物

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4370324A (en) 1980-09-17 1983-01-25 Bernstein Joel E Method and composition for treating and preventing irritation of the eyes
US4407791A (en) 1981-09-28 1983-10-04 Alcon Laboratories, Inc. Ophthalmic solutions
US4749700A (en) * 1984-10-23 1988-06-07 Nastech Pharmaceutical Co, Inc. Novel methods of administering antihistamines, antinausea and antiemetic pharmaceutical agents and novel dosage forms containing same
US4923892A (en) 1985-08-17 1990-05-08 Burroughs Wellcome Co. Tricyclic aromatic compounds
GB8520662D0 (en) * 1985-08-17 1985-09-25 Wellcome Found Tricyclic aromatic compounds
JPS6310784A (ja) * 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤
DE3877904D1 (de) * 1987-11-13 1993-03-11 Asta Pharma Ag Azelastin enthaltende arzneimittel zur anwendung in der nase und/oder am auge.
IT1250691B (it) * 1991-07-22 1995-04-21 Giancarlo Santus Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac.
JP3662944B2 (ja) 1993-08-24 2005-06-22 協和醗酵工業株式会社 点鼻剤
US5897858A (en) * 1994-02-03 1999-04-27 Schering-Plough Healthcare Products, Inc. Nasal spray compositions exhibiting increased retention in the nasal cavity
US5641805A (en) * 1995-06-06 1997-06-24 Alcon Laboratories, Inc. Topical ophthalmic formulations for treating allergic eye diseases
AU7833698A (en) * 1997-06-09 1998-12-30 Bridge Pharma, Inc. Compounds with combined antihistaminic and mast cell stabilizing activities, intended for ophthalmic use
DE69900207T2 (de) 1998-07-14 2001-11-22 Alcon Laboratories, Inc. Verwendung von 11-(3-dimethylaminopropyliden)-6,11-dihydrodibenz[b,e]oxepin-2-essigsäure und deren pharmazeutisch annehmbaren salzen zur herstellung eines medikaments zur behandlung nicht-allergisch-bedingten augenentzündungen und zur prevention der okularen neovaskularisation
BR9914799A (pt) * 1998-10-27 2001-07-10 Alcon Lab Inc Sistema conservante para composições farmacêuticas administráveis topicamente contendo um sabão de ácido graxo/aminoácido
US6146622A (en) * 1998-10-27 2000-11-14 Alcon Laboratories, Inc. Use of certain anionic amino acid based surfactants to enhance antimicrobial effectiveness of topically administrable pharmaceutical compositions
US6274626B1 (en) * 1998-12-22 2001-08-14 Bausch & Lomb Incorporated Pheniramine-containing compositions and method for treating allergic responses
US6174914B1 (en) * 1999-06-15 2001-01-16 Alcon Laboratories, Inc. Method of inhibiting cytokine release from human ocular cells
EP1214094A1 (en) 1999-09-21 2002-06-19 Alcon Laboratories, Inc. Use of fatty acid/amino acid soaps to enhance antimicrobial effectiveness of topical pharmaceutical compositions
MXPA02005007A (es) 1999-11-18 2004-08-12 Alcon Inc Uso de un antagonista h1 y un esteroide inocuo para tratar condiciones oculares.
US6375973B2 (en) 2000-01-25 2002-04-23 Alcon Universal Ltd. Ophthalmic anti-allergy compositions suitable for use with contact lenses
PE20020578A1 (es) 2000-10-10 2002-08-14 Upjohn Co Una composicion de antibiotico topico para el tratamiento de infecciones oculares
TWI231759B (en) 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
JP2006508138A (ja) 2002-11-12 2006-03-09 アルコン，インコーポレイテッド アレルギー性鼻炎を処置するための抗アレルギー剤およびステロイドの使用

Also Published As

Publication number Publication date
PL367780A1 (en) 2005-03-07
JP2004536096A (ja) 2004-12-02
TWI231759B (en) 2005-05-01
US20030055102A1 (en) 2003-03-20
JP2009114213A (ja) 2009-05-28
CN1525849A (zh) 2004-09-01
MXPA03011947A (es) 2004-03-26
EP1399127B1 (en) 2005-05-11
CN1211125C (zh) 2005-07-20
US20050158387A1 (en) 2005-07-21
CA2447924A1 (en) 2003-01-09
WO2003002093A1 (en) 2003-01-09
CA2447924C (en) 2009-11-03
ATE295149T1 (de) 2005-05-15
US6995186B2 (en) 2006-02-07
JP5328947B2 (ja) 2013-10-30
BRPI0210707B8 (pt) 2021-05-25
JP2012107046A (ja) 2012-06-07
DK1399127T3 (da) 2005-06-13
ES2238574T3 (es) 2005-09-01
ZA200308771B (en) 2005-01-26
US7402609B2 (en) 2008-07-22
DE60204142T2 (de) 2005-10-06
BRPI0210707B1 (pt) 2015-08-04
DE60204142D1 (de) 2005-06-16
JP2013127005A (ja) 2013-06-27
BR0210707A (pt) 2004-07-20
AR034619A1 (es) 2004-03-03
KR100884711B1 (ko) 2009-02-19
HK1059573A1 (en) 2004-07-09
JP2010150292A (ja) 2010-07-08
GC0000397A (en) 2007-03-31
PL205565B1 (pl) 2010-05-31
JP4827374B2 (ja) 2011-11-30
AU2002310461B2 (en) 2006-05-18
KR20040025919A (ko) 2004-03-26
EP1399127A1 (en) 2004-03-24

Similar Documents

Publication Publication Date Title
PT1399127E (pt) Formulacoes de olopatadina para administracao topica
FI20011478A0 (fi) Farmaseuttinen koostumus
CY2013011I2 (el) Μεθοδος χορηγησης διφωσφονικων
PT2336184E (pt) Administração de agentes para o tratamento da inflamação
PT1605956E (pt) Administração de capsaicinóides para o tratamento da osteoartrite
DK1335725T3 (da) Anvendelse af CCI-779 som et antineoplastisk middel
NO20035366L (no) Benzoylsulfonamider og sulfonylbenzamidiner for anvendelse som antitumormidler
NO20042807L (no) Farmasoytiske sammensetninger som innbefatter aktive vitamin D forbindelser
NO20033384D0 (no) Farmasöytisk formulering
EP1383518A4 (en) ORAL DELIVERY OF MACROMOLECULES
DK1524266T3 (da) Farmaceutisk sammensætning
EE200300416A (et) Ravimvorm
EE05020B1 (et) Glburiidi ravimkoostis
ATE393626T1 (de) Transnasale anticonvulsive zusammensetzungen
NO20035627D0 (no) Farmasöytisk formulering
IS7051A (is) Lyfjasamsetningar
PT1210119E (pt) Composicoes farmaceuticas para administracao oral e topica
NO20040860L (no) Farmasoytisk sammensetning som innbefatter lumiracoxib
FI20022128L (fi) Farmaseuttinen koostumus
DE50209245D1 (de) Neuroprotektives medikament
HUP0400115A3 (en) Pharmaceutical composition for the intramuscular administration of fulvestrant
NO20034556L (no) Imidazotriazinon-holdige sammensetninger for nasal administrering
DE50104030D1 (de) Synchronisiervorrichtung
PT1385512E (pt) Utilizacao de derivados de piridoindolona para preparacao de medicamentos anticancerigenos
EP1413314A4 (en) MEDICAL COMPOSITIONS